Portal CD4+ and CD8+ T lymphocyte correlate to intensity of interface hepatitis in chronic hepatitis C

Ana Teresa Rodriguez Viso1, Thaís de Castro Barbosa, Lídia Yamamoto

  • 1Departamento de Moléstias Infecciosas e Parasitárias, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP. ar-viso@uol.com.br

Insights

High numbers of CD4+ and CD8+ T lymphocytes (TL) in chronic hepatitis C correlate with liver inflammation severity. This suggests intrahepatic T cells play a key role in disease progression, supporting an immune-mediated pathogenesis.

Area of Science:

  • Hepatology
  • Immunology
  • Virology

Background:

  • The exact mechanisms driving chronic hepatitis C pathogenesis remain unclear.
  • While CD4+ and CD8+ T lymphocytes (TL) are present in affected livers, their specific roles are not fully understood.

Purpose of the Study:

  • To investigate the functional role of CD4+ and CD8+ TL in chronic hepatitis C progression.
  • To correlate T lymphocyte presence and density with histological and laboratory findings.

Main Methods:

  • Quantification of CD4+ and CD8+ TL using immunohistochemistry in 39 chronic hepatitis C liver biopsies.
  • Association of T lymphocyte counts with demographic data, histology, lab results, and hepatitis C genotypes.

Main Results:

  • Elevated CD4+ and CD8+ TL were observed in portal and periportal spaces, with CD4+ TL being more numerous.
  • Both CD4+ and CD8+ TL showed a direct correlation with the intensity of interface hepatitis.
  • CD8+ TL levels correlated with elevated serum enzyme levels.

Conclusions:

  • The abundance of intrahepatic CD4+ and CD8+ TL and their link to interface hepatitis suggest T lymphocytes are crucial in hepatitis C evolution.
  • These findings support the hypothesis that chronic hepatitis C pathogenesis involves immune-mediated mechanisms driven by intrahepatic T cells.
Abstract

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...